Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


Country Product ID Public Price Currency Agent Laboratory Form Dosage Package Size Packaging Route Composition ATC Presentation Pricing Date
Denmark 450309 2772.45 DKK Novartis Solution for infusion 4mg/100ml 100ml 100 ml Zoledronic acid M05BA08 05/11/2018
Finland 136672 EUR Novartis Solution for infusion 4mg/100ml 5 5kpl Zoledronic acid M05BA08 Bottle 22/04/2021
Finland 44126 EUR Novartis Solution for infusion 4mg/5ml 4x4 mg 4mg Zoledronic acid M05BA08 Vial 22/04/2021
Finland 44127 EUR Novartis Solution for infusion 4mg/5ml 10x4 mg 4mg Zoledronic acid M05BA08 Vial 22/04/2021
Finland 21221 EUR Novartis Powder for solution for injection 4mg/5ml 4x(4 mg + 5ml) 1kpl Zoledronic acid M05BA08 Vial 22/04/2021
Finland 21222 EUR Novartis Powder for solution for injection 4mg/5ml 10 1kpl Zoledronic acid M05BA08 Vial 22/04/2021
Finland 136674 EUR Novartis Solution for infusion 4mg/100ml 4 4kpl Zoledronic acid M05BA08 Bottle 22/04/2021
Finland 136673 EUR Novartis Solution for infusion 4mg/100ml 1 1kpl Zoledronic acid M05BA08 Bottle 22/04/2021
Norway 450309 1443.3 NOK Novartis Europharm Limited (1) Solution for infusion 4mg/100ml 1x100ml Flaske Zoledronic acid M05BA08 Flaske/1/100/ml 01/04/2020
Sweden 20101210100130 2633.5 SEK Novartis Sverige AB Solution for infusion 4mg/100ml 1 1 st (1x100ml) Zoledronic acid M05BA08 Injektionsflaska 23/04/2020